Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Shijing Yue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9155-488X; OpenAlex author ID A5076967246. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Exosomal miR-92a-3p promotes pancreatic cancer cells' extravasation by inducing vascular permeability through inhibition of DAB2IP. Last author DOI 10.1038/s41419-026-08719-9↗
  2. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. First author DOI 10.1002/ijc.29324↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Luhan Li · 1 shared paper, 2026 · strength 0.26
  2. Jihui Hao · 1 shared paper, 2026 · strength 0.26
  3. Nathalia A. Giese · 1 shared paper, 2015 · strength 0.05
  4. Bindhu K. Madhavan · 1 shared paper, 2015 · strength 0.05
  5. Markus Wolfgang Büchler · 1 shared paper, 2015 · strength 0.05
  6. Margot Zöller · 1 shared paper, 2015 · strength 0.05
  7. Holger Kalthoff · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.